1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D7F5BFF8605663B685257D0F005FF30F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/D7F5BFF8605663B685257D0F005FF30F!OpenDocument
18
19OpenDocument
2034.239.152.207
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Thought Leader Services

Document Excerpt: Effective Thought Leader Management: Interaction Tactics and Challenges

DB Image

ID: MD-420


Features:

10 Info Graphics

14 Data Graphics

130+ Metrics

3 Narratives


Pages/Slides: 4


Published: Pre-2018


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt" on the right.


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5316 "Effective Thought Leader Management: Interaction Tactics and Challenges."


Industries Profiled:
Health Care; Pharmaceutical; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Manufacturing; Medical Device; Consumer Products; Diagnostic; Technology


Companies Profiled:
Sanofi; Shire; Astellas; AstraZeneca; Genentech; Dr Reddy's Laboratories; Biogen; Merck; Eli Lilly; Teva Pharmaceutical Industries Ltd; Biocon; United Therapeutics; Amgen; Baxter Healthcare; Acorda Therapeutics; Upsher-Smith; Crescendo Bioscience; ProStrakan; Cubist Pharmaceuticals; Pierre Fabre Medicament; Ironwood; Kadmon Pharmaceuticals; Covidien; Roche; Medtronic; GE Healthcare; Bayer Healthcare; BARD; BD

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.